IRCT20180404039187N2已完成3 期
study the effects of Allopurinol on liver enzymes and grade of fatty liver on ultrasound in patients with non-alcoholic fatty liver disease
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •patients whom have non-alcoholic fatty liver disease based on the ultrasound and laboratory tests
- •patients whom have non-symptomatic hyperuricemia (serum uric acid >7 mg/dl for men and >6.5 mg/dl for women)
排除标准
- •pregnancy and lactation
- •allergy to Allopurinol or its contents
- •use of alcohol
- •patients with renal deficiency with creatinine clearance (GFR) <30 mg/ml
- •simultaneous use of drugs which have interaction with Allopurinol (mercaptopurine, azathioprine, ...)
- •patients who have had gout or who are using uricosuric agents or thiazide diuretics
研究者
相似试验
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
已完成
2 期
Evaluation of the effect of Allopurinol in reducing heart damage in acute ischemic heart patientsIRCT20111206008307N36Tabriz University of Medical Sciences100
已完成
4 期
The Effects of Allopurinol in Chronic Kidney Disease PatientsRenal and Urogenital - Kidney diseaseChronic Kidney DiseaseACTRN12614000320651Dilara Bayram60
招募中
3 期
Effect of allopurinol on diabetic nephropathyIRCT20200117046158N1Shahre-kord University of Medical Sciences60
招募中
不适用
Inhibitory effect of therapeutic medicine on liver disease progression in metabolic dysfunction-associated fatty liver disease patientmetabolic dysfunction-associated fatty liver diseaseJPRN-UMIN000044364Department of Gastroenterology, Hokkaido University Hospital500